Yuehua Li

Yuehua Li

Auto-generated profile, based on publicly available information

Yuehua Li

Key Laboratory of Targeted Intervention of Cardiovascular Disease Collaborative Innovation Center for Cardiovascular Disease Translational Medicine School of Basic Medical Science Nanjing Medical University Nanjing Jiangsu China

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2024 in JCI Insight
Verified
Journal Article
Open access
PDF file
WYWansu Yu
Wansu Yu
QKQiuyue Kong
Qiuyue Kong
SJSurong Jiang
Surong Jiang
YLYunfan Li
Yunfan Li
ZWZhaohe Wang
Zhaohe Wang
LLLi Liu
Li Liu
Myocardial ischemia/reperfusion (MI/R) injury is a major cause of adverse outcomes of revascularization following myocardial infarction. Anaerobic glycolysis during myocardial ischemia is well studied, but the role of aerobic glycolysis during the early phase of reperfusion is incompletely understood. Lactylation of Histone H3 (H3) is an epigenetic indicator of the glycolytic switch. Heat shock protein A12A (HSPA12A) is an atypic member of the HSP70 family. In the present study, we report that, during reperfusion following myocardial ischemia, HSPA12A was downregulated and aerobic glycolytic flux was decreased in cardiomyocytes. Notably, HSPA12A KO in mice exacerbated MI/R-induced aerobic glycolysis decrease, cardiomyocyte death, and cardiac dysfunction. Gain- and loss-of-function studies demonstrated that HSPA12A was required to support cardiomyocyte survival upon hypoxia/reoxygenation (H/R) challenge and that its protective effects were mediated by maintaining aerobic glycolytic homeostasis for H3 lactylation. Further analyses revealed that HSPA12A increased Smurf1-mediated Hif1α protein stability, thus increasing glycolytic gene expression to maintain appropriate aerobic glycolytic activity to sustain H3 lactylation during reperfusion and, ultimately, improving cardiomyocyte survival to attenuate MI/R injury.

1 February 2015 in Journal of Molecular and Cellular Cardiology
Verified
Journal Article
Closed access
JSJuan Song
Juan Song
YZYun Zhu
Yun Zhu
JLJiantao Li
Jiantao Li
JLJiahao Liu
Jiahao Liu
YGYun Gao
Yun Gao
YLYuehua Li
Yuehua Li

1 October 2001 in American Journal of Respiratory Cell and Molecular Biology
Verified
Journal Article
Closed access
KAKenneth B. Adler
Kenneth B. Adler
YLYuehua Li
Yuehua Li

1 February 2020 in Basic Research in Cardiology
Verified
Journal Article
Closed access
PDF file
XLXia Lu
Xia Lu
YHYijie He
Yijie He
CTChao Tang
Chao Tang
XWXiaoyang Wang
Xiaoyang Wang
LQLinli Que
Linli Que
YLYuehua Li
Yuehua Li

10 June 2009 in Surgery
Verified
Journal Article
Closed access
PDF file
XXXuan Xu
Xuan Xu
ZCZhijuan Cao
Zhijuan Cao
BCBin Cao
Bin Cao
JLJing Li
Jing Li
LGLin Guo
Lin Guo
YLYuehua Li
Yuehua Li

15 December 2022 in The FASEB Journal
Verified
Journal Article
Closed access
CTChao Tang
Chao Tang
YHYu‐Xing Hou
Yu‐Xing Hou
PSPeng‐Xi Shi
Peng‐Xi Shi
CZCheng‐Hao Zhu
Cheng‐Hao Zhu
XLXia Lu
Xia Lu
YLYue‐Hua Li
Yue‐Hua Li